• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HIV暴露前预防的知识领域与新兴趋势：一种基于CiteSpace的可视化分析

Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis CiteSpace.

作者信息

Chen Xi, Lai Yu

机构信息

School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Microbiol. 2023 Mar 16;14:1099132. doi: 10.3389/fmicb.2023.1099132. eCollection 2023.

DOI:10.3389/fmicb.2023.1099132
PMID:37007528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10060873/
Abstract

BACKGROUND

As an effective strategy that reduces transmission among people at high risk of human immunodeficiency virus (HIV), pre-exposure prophylaxis (PrEP) has revolutionized HIV prevention. Our study aims to provide a reference for the development of relevant research and the formulation of prevention and control policies for HIV.

METHODS

Through CiteSpace software, this study aims to present a comprehensive overview of the HIV PrEP knowledge structure, hotspots, and frontiers. We searched the Web of Science Core Collection for studies published between 2012 and 2022 related to HIV PrEP, and 3,243 papers remained after selection.

RESULTS

The number of HIV PrEP publications has increased over the past few years. A close integration and exchange of HIV PrEP research findings has taken place between countries and authors. Major ongoing research trends include long-term injection PrEP, the impact of chlamydia on HIV PrEP, and individual awareness of and attitudes toward HIV PrEP. Thus, more attention should be paid to innovations and breakthroughs in drugs, the factors that affect HIV transmission and susceptibility, and the future promotion of public acceptance of HIV PrEP.

CONCLUSION

This study offers a systematic, objective, and comprehensive analysis of the related articles. It will assist scholars in understanding the dynamic evolution of HIV PrEP research and identifying future research areas to better advance the development of the field.

摘要

背景

作为一种减少人类免疫缺陷病毒（HIV）高危人群之间传播的有效策略，暴露前预防（PrEP）彻底改变了HIV预防模式。我们的研究旨在为HIV相关研究的开展及防控政策的制定提供参考。

方法

本研究旨在通过CiteSpace软件全面概述HIV PrEP的知识结构、热点及前沿。我们在科学网核心合集数据库中检索了2012年至2022年间发表的与HIV PrEP相关的研究，筛选后保留3243篇论文。

结果

过去几年中，HIV PrEP相关出版物数量有所增加。各国及作者之间在HIV PrEP研究成果方面进行了紧密的整合与交流。当前主要的研究趋势包括长效注射PrEP、衣原体对HIV PrEP的影响以及个体对HIV PrEP的认知和态度。因此，应更加关注药物创新与突破、影响HIV传播和易感性的因素以及未来提高公众对HIV PrEP的接受度。

结论

本研究对相关文章进行了系统、客观且全面的分析。它将帮助学者了解HIV PrEP研究的动态演变，并确定未来的研究领域，以更好地推动该领域的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/b30e5cb090c9/fmicb-14-1099132-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/1b88af6f89c7/fmicb-14-1099132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/659ad612b129/fmicb-14-1099132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/a8c8d5ad5b41/fmicb-14-1099132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/4b1e969636da/fmicb-14-1099132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/ad9414f7561a/fmicb-14-1099132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/641fff20a1f6/fmicb-14-1099132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/69925ff51e29/fmicb-14-1099132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/95157fe3b9c4/fmicb-14-1099132-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/367c6bb41bc4/fmicb-14-1099132-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/b30e5cb090c9/fmicb-14-1099132-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/1b88af6f89c7/fmicb-14-1099132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/659ad612b129/fmicb-14-1099132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/a8c8d5ad5b41/fmicb-14-1099132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/4b1e969636da/fmicb-14-1099132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/ad9414f7561a/fmicb-14-1099132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/641fff20a1f6/fmicb-14-1099132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/69925ff51e29/fmicb-14-1099132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/95157fe3b9c4/fmicb-14-1099132-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/367c6bb41bc4/fmicb-14-1099132-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/10060873/b30e5cb090c9/fmicb-14-1099132-g010.jpg

相似文献

1
Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis CiteSpace.HIV暴露前预防的知识领域与新兴趋势：一种基于CiteSpace的可视化分析
Front Microbiol. 2023 Mar 16;14:1099132. doi: 10.3389/fmicb.2023.1099132. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区，服用抗叶酸抗疟药物的人群中，叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.低收入和中等收入国家男男性行为者对艾滋病病毒暴露前预防的知晓率及使用意愿：一项系统评价和荟萃分析
J Int AIDS Soc. 2017 Jun 26;20(1):21580. doi: 10.7448/IAS.20.1.21580.
4
Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data.提高男男性行为者对 HIV 暴露前预防 (PrEP) 的认识和使用 HIV PrEP 的意愿：全球数据的系统评价和荟萃分析。
J Int AIDS Soc. 2022 Mar;25(3):e25883. doi: 10.1002/jia2.25883.
5
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.意大利艾滋病毒/艾滋病感染者中对艾滋病毒暴露前预防的认知、讨论及非处方使用情况：一项针对接受抗逆转录病毒治疗的患者及其治疗艾滋病毒的医生的全国性横断面研究。
BMC Infect Dis. 2017 Nov 28;17(1):734. doi: 10.1186/s12879-017-2819-5.
6
Pre-exposure Prophylaxis in HIV Research: A Latent Dirichlet Allocation Analysis (GAPRESEARCH).HIV 研究中的暴露前预防：潜在狄利克雷分配分析（GAPRESEARCH）。
AIDS Rev. 2020 Jul 8;22(2):103-111. doi: 10.24875/AIDSRev.20000131.
7
Bridging Awareness and Acceptance of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men and the Need for Targeting Chemsex and HIV Testing: Cross-Sectional Survey.男男性行为者对暴露前预防的认知与接受程度及针对药物滥用性行为和艾滋病毒检测的必要性：横断面调查
JMIR Public Health Surveill. 2019 Jul 3;5(3):e13083. doi: 10.2196/13083.
8
Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review.绘制 HIV 暴露前预防研究文献的研究主题和特征图谱：一项范围综述的方案。
BMJ Open. 2019 May 24;9(5):e024212. doi: 10.1136/bmjopen-2018-024212.
9
Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.一项针对HIV感染高危人群的开放标签、单臂HIV暴露前预防（PrEP）试验方案：新南威尔士州示范项目PRELUDE。
BMJ Open. 2016 Jun 20;6(6):e012179. doi: 10.1136/bmjopen-2016-012179.
10
Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.韩国医务人员和男男性行为者对 HIV 暴露前预防的认识和接受程度。
J Korean Med Sci. 2018 Mar 19;33(12):e91. doi: 10.3346/jkms.2018.33.e91.

引用本文的文献

1
Global research landscape of HIV and Kaposi's sarcoma: a visualized bibliometric analysis.全球HIV与卡波西肉瘤的研究格局：一项可视化文献计量分析
Front Microbiol. 2025 Jun 25;16:1601245. doi: 10.3389/fmicb.2025.1601245. eCollection 2025.
2
HIV and the gut microbiome: future research hotspots and trends.人类免疫缺陷病毒与肠道微生物群：未来研究热点与趋势
Front Microbiol. 2025 Feb 7;16:1466419. doi: 10.3389/fmicb.2025.1466419. eCollection 2025.
3
Mechanisms of HIV-immunologic non-responses and research trends based on gut microbiota.

本文引用的文献

1
Antibacterial properties of lactoferrin: A bibliometric analysis from 2000 to early 2022.乳铁蛋白的抗菌特性：2000年至2022年初的文献计量分析
Front Microbiol. 2022 Aug 17;13:947102. doi: 10.3389/fmicb.2022.947102. eCollection 2022.
2
Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?长效卡博特韦是否是有生育潜力女性的暴露前预防选择？
Open Forum Infect Dis. 2022 May 11;9(7):ofac230. doi: 10.1093/ofid/ofac230. eCollection 2022 Jul.
3
Update and latest advances in antiretroviral therapy.
基于肠道微生物群的HIV免疫无反应机制及研究趋势
Front Immunol. 2024 Dec 26;15:1378431. doi: 10.3389/fimmu.2024.1378431. eCollection 2024.
抗逆转录病毒治疗的最新进展和研究动态。
Trends Pharmacol Sci. 2022 Jan;43(1):16-29. doi: 10.1016/j.tips.2021.10.004. Epub 2021 Nov 3.
4
Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis.全球髋部骨折研究趋势和热点：20 年文献计量分析。
Arch Osteoporos. 2021 Apr 17;16(1):73. doi: 10.1007/s11657-021-00929-2.
5
Epilepsy Occurrence and Circadian Rhythm: A Bibliometrics Study and Visualization Analysis via CiteSpace.癫痫发作与昼夜节律：一项通过CiteSpace的文献计量学研究与可视化分析
Front Neurol. 2020 Nov 5;11:984. doi: 10.3389/fneur.2020.00984. eCollection 2020.
6
Current Perspectives on the Impact of Pre-Exposure Prophylaxis Stigma Regarding Men Who Have Sex with Men in the United States.美国男男性行为者暴露前预防污名化影响的当前观点
HIV AIDS (Auckl). 2020 May 18;12:187-192. doi: 10.2147/HIV.S214380. eCollection 2020.
7
Advancing Novel PrEP Products - Alternatives to Non-Inferiority.推进新型暴露前预防产品——非劣效性的替代方案
Stat Commun Infect Dis. 2019 Jan;11(1). doi: 10.1515/scid-2019-0011. Epub 2019 Aug 6.
8
[The role of biomedical interventions in HIV prevention: Pre-exposure Prophylaxis (PrEP)].生物医学干预措施在HIV预防中的作用：暴露前预防（PrEP）
Semergen. 2020 Apr;46(3):202-207. doi: 10.1016/j.semerg.2019.06.006. Epub 2019 Aug 5.
9
Racial and Ethnic Disparities in HIV Pre-exposure Prophylaxis Awareness Among Men Who have Sex with Men.男男性行为者中艾滋病病毒前暴露预防意识的种族和民族差异。
AIDS Behav. 2019 Oct;23(10):2706-2709. doi: 10.1007/s10461-019-02462-3.
10
Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.淋病和衣原体诊断作为 HIV 暴露前预防的切入点：一项建模研究。
BMJ Open. 2019 Mar 4;9(3):e023453. doi: 10.1136/bmjopen-2018-023453.